3, 3' -spiroindolinone derivatives as anticancer agents

Details for Australian Patent Application No. 2010215554 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Zhang, Jing; Zhang, Zhuming

Agent Davies Collison Cave

Pub. Number AU-A-2010215554

PCT Pub. Number WO2010/094622

Priority 61/153,089 17.02.09 US

Filing date 12 February 2010

Wipo publication date 26 August 2010

International Classifications

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/438 (2006.01) - the ring being spiro-condensed with carbocyclic or heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/094622 Priority application(s): WO2010/094622

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215563-Method and device for monitoring a photovoltaic unit

2010215539-Glycolipid mixture with antiinflammatory acivity obtained from Oscillatoria Planktothrix